Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2024

Description

Systemic aspergillosis, the most lethal form of aspergillosis, occurs when the infection extends beyond the lungs to affect other organs. On the other hand, systemic candidiasis encompasses a range of yeast infections caused by various Candida species. Both conditions are serious illnesses capable of damaging organs such as the blood, heart, brain, eyes, bones, and others.

The primary types of treatments for systemic aspergillosis and systemic candidiasis include systemic oral azoles, voriconazole, liposomal amphotericin B, topical antifungal agents, and others. Systemic oral azoles constitute a class of antifungal medications taken orally to combat systemic fungal infections throughout the body. These drugs target specific enzymes crucial for fungal survival, thereby inhibiting the growth and replication of fungal cells. They find application in treating conditions such as allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), gastrointestinal candidiasis, genitourinary tract candidiasis, and others. The usage is prevalent in clinics, hospitals, and other healthcare settings.

The systemic aspergillosis and systemic candidiasis research report is one of a series of new reports from The Business Research Company that provides systemic aspergillosis and systemic candidiasis market statistics, including the systemic aspergillosis and systemic candidiasis industry's global market size, regional shares, competitors with systemic aspergillosis and systemic candidiasis market share, detailed systemic aspergillosis and systemic candidiasis market segments, market trends and opportunities, and any further data you may need to thrive in the systemic aspergillosis and systemic candidiasis industry. This systemic aspergillosis and systemic candidiasis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The systemic aspergillosis and systemic candidiasis market size has grown strongly in recent years. It will grow from $6.82 billion in 2023 to $7.2 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The increase observed in the historical period can be attributed to factors such as the rising incidence of fungal infections, a population with compromised immune systems, advancements in diagnostic technologies, an increase in invasive medical procedures, and the global spread of infections.

The systemic aspergillosis and systemic candidiasis market size is expected to see steady growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in the forecast period can be linked to efforts in global antifungal resistance surveillance, an aging population, the adoption of telemedicine for remote consultations, a shift toward patient-centric drug development, and the implementation of digital health solutions for patient management. Key trends expected in the forecast period encompass the identification of new fungal biomarkers for early detection, the emergence of novel antifungal agents, advancements in immunotherapy, and the development of innovative drug delivery systems.

The anticipated increase in the incidence of fungal diseases is poised to drive the systemic aspergillosis and systemic candidiasis market's growth. Fungal diseases encompass infections caused by fungi, affecting various body parts and leading to diverse symptoms and complications. These infections range from cutaneous skin issues to respiratory and systemic infections. Antifungal medications, including oral azoles, voriconazole, and liposomal amphotericin B, are commonly employed in treating fungal diseases. For instance, as of March 2023, the Centers for Disease Control and Prevention reported a rise in clinical cases of Candida auris, an emerging fungus, from 476 cases in 2019 to 1,471 cases in 2021 in the United States. Screening cases also tripled from 2020 to 2021, reaching 4,041 cases. Consequently, the increasing incidence of fungal diseases is a key driver of the systemic aspergillosis and systemic candidiasis market.

The upward trajectory in healthcare expenditures is expected to contribute to the systemic aspergillosis and systemic candidiasis market's growth. Healthcare expenditures represent the total spending on medical services, treatments, and health-related expenses within a specified period. Elevated healthcare expenditures play a crucial role in managing systemic aspergillosis and systemic candidiasis by ensuring timely access to antifungal medications, advanced diagnostic tools, and specialized care, thereby improving patient outcomes and reducing mortality rates. Notably, as of December 2022, the Centers for Medicare & Medicaid Services reported a 2.7% increase in healthcare spending in the United States, reaching $12,914 per person in 2021, totaling $4.3 trillion. Healthcare spending accounted for 18.3% of the nation's GDP. Therefore, the surge in healthcare expenditures is a significant driver of the systemic aspergillosis and systemic candidiasis market.

A noteworthy trend in the systemic aspergillosis and systemic candidiasis markets is the emphasis on product innovation by major companies to maintain their market positions. For instance, in October 2021, Intas Pharmaceuticals Limited, an India-based pharmaceutical formulation development, manufacturing, and marketing company, introduced the world's first Super Bioavailable Itraconazole-SB 100mg under the brand name Itaspor-SB Forte/Subawin. This innovative product, designed to enhance patient compliance, allows for reduced dosing and can be consumed with or without food, simply with water. Such product innovations play a vital role in meeting the evolving needs of patients and healthcare professionals.

Major companies in the systemic aspergillosis and systemic candidiasis market are also focusing on advanced solutions, such as next-generation anti-fungal drug agents, to address the growing demand for more effective and targeted treatments. Next-generation anti-fungal drug agents involve advanced medications designed to combat fungal infections more effectively, often incorporating innovative mechanisms or formulations to enhance efficacy and reduce resistance. For example, in October 2023, BDR Pharmaceutical, a US-based pharmaceutical company, launched Zisavel capsules for treating invasive aspergillosis and mucormycosis. This product, belonging to the isavuconazoles class of medications, plays a crucial role in treating invasive aspergillosis and offers a first-line treatment for the specified fungal infections.

In April 2021, Pfizer Inc., a US-based research-based biopharmaceutical company, successfully acquired Amplyx Pharmaceuticals Inc. for an undisclosed amount. This strategic acquisition enables Pfizer to take ownership of Amplyx's early-stage pipeline, featuring potential antiviral (MAU868) and antifungal (APX2039) drugs. Amplyx Pharmaceuticals Inc. is a US-based developer specializing in antifungal agents.

Major companies operating in the systemic aspergillosis and systemic candidiasis market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Matinas BioPharma Holdings Inc., Shionogi & Co. Ltd., Cipla Limited, Taj Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Cidara Therapeutics Inc., T2 Biosystems Inc., Sandoz International GmbH, Grupo Ferrer International S.A., Entasis Therapeutics Inc., NovaDigm Therapeutics Inc., F2G Ltd., Mycovia Pharmaceuticals Inc., ContraFect Corporation, Enzon Pharmaceutical Inc., Pacgen Life Science Corporation, Biosergen AS, N8 Medical LLC

North America was the largest region in the systemic aspergillosis and systemic candidiasis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the systemic aspergillosis and systemic candidiasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the systemic aspergillosis and systemic candidiasis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The systemic aspergillosis and systemic candidiasis market consists of sales of voriconazole and amphotericin B. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on systemic aspergillosis and systemic candidiasis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for systemic aspergillosis and systemic candidiasis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The systemic aspergillosis and systemic candidiasis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Systemic Oral Azoles; Voriconazole; Liposomal Amphotericin B; Topical Antifungal Agents; Other Types
2) By Application: Allergic Bronchopulmonary Aspergillosis (ABPA); Chronic Pulmonary Aspergillosis (CPA); Gastrointestinal Candidiasis; Genitourinary Tract Candidiasis; Other Applications
3) By End User: Clinic; Hospital; Other End Users
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13880

1. Executive Summary

2. Systemic Aspergillosis And Systemic Candidiasis Market Characteristics

3. Systemic Aspergillosis And Systemic Candidiasis Market Trends And Strategies

4. Systemic Aspergillosis And Systemic Candidiasis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Systemic Aspergillosis And Systemic Candidiasis Market Size and Growth

5.1. Global Systemic Aspergillosis And Systemic Candidiasis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Systemic Aspergillosis And Systemic Candidiasis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Systemic Aspergillosis And Systemic Candidiasis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Systemic Aspergillosis And Systemic Candidiasis Market Segmentation

6.1. Global Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Systemic Oral Azoles
Voriconazole
Liposomal Amphotericin B
Topical Antifungal Agents
Other Types
6.2. Global Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Allergic Bronchopulmonary Aspergillosis (ABPA)
Chronic Pulmonary Aspergillosis (CPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other Applications
6.3. Global Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinic
Hospital
Other End Users

7. Systemic Aspergillosis And Systemic Candidiasis Market Regional And Country Analysis

7.1. Global Systemic Aspergillosis And Systemic Candidiasis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Systemic Aspergillosis And Systemic Candidiasis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Systemic Aspergillosis And Systemic Candidiasis Market

8.1. Asia-Pacific Systemic Aspergillosis And Systemic Candidiasis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Systemic Aspergillosis And Systemic Candidiasis Market

9.1. China Systemic Aspergillosis And Systemic Candidiasis Market Overview
9.2. China Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Systemic Aspergillosis And Systemic Candidiasis Market

10.1. India Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Systemic Aspergillosis And Systemic Candidiasis Market

11.1. Japan Systemic Aspergillosis And Systemic Candidiasis Market Overview
11.2. Japan Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Systemic Aspergillosis And Systemic Candidiasis Market

12.1. Australia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Systemic Aspergillosis And Systemic Candidiasis Market

13.1. Indonesia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Systemic Aspergillosis And Systemic Candidiasis Market

14.1. South Korea Systemic Aspergillosis And Systemic Candidiasis Market Overview
14.2. South Korea Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Systemic Aspergillosis And Systemic Candidiasis Market

15.1. Western Europe Systemic Aspergillosis And Systemic Candidiasis Market Overview
15.2. Western Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Systemic Aspergillosis And Systemic Candidiasis Market

16.1. UK Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Systemic Aspergillosis And Systemic Candidiasis Market

17.1. Germany Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Systemic Aspergillosis And Systemic Candidiasis Market

18.1. France Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Systemic Aspergillosis And Systemic Candidiasis Market

19.1. Italy Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Systemic Aspergillosis And Systemic Candidiasis Market

20.1. Spain Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Systemic Aspergillosis And Systemic Candidiasis Market

21.1. Eastern Europe Systemic Aspergillosis And Systemic Candidiasis Market Overview
21.2. Eastern Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Systemic Aspergillosis And Systemic Candidiasis Market

22.1. Russia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Systemic Aspergillosis And Systemic Candidiasis Market

23.1. North America Systemic Aspergillosis And Systemic Candidiasis Market Overview
23.2. North America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Systemic Aspergillosis And Systemic Candidiasis Market

24.1. USA Systemic Aspergillosis And Systemic Candidiasis Market Overview
24.2. USA Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Systemic Aspergillosis And Systemic Candidiasis Market

25.1. Canada Systemic Aspergillosis And Systemic Candidiasis Market Overview
25.2. Canada Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Systemic Aspergillosis And Systemic Candidiasis Market

26.1. South America Systemic Aspergillosis And Systemic Candidiasis Market Overview
26.2. South America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Systemic Aspergillosis And Systemic Candidiasis Market

27.1. Brazil Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Systemic Aspergillosis And Systemic Candidiasis Market

28.1. Middle East Systemic Aspergillosis And Systemic Candidiasis Market Overview
28.2. Middle East Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Systemic Aspergillosis And Systemic Candidiasis Market

29.1. Africa Systemic Aspergillosis And Systemic Candidiasis Market Overview
29.2. Africa Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Systemic Aspergillosis And Systemic Candidiasis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Systemic Aspergillosis And Systemic Candidiasis Market Competitive Landscape And Company Profiles

30.1. Systemic Aspergillosis And Systemic Candidiasis Market Competitive Landscape
30.2. Systemic Aspergillosis And Systemic Candidiasis Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Systemic Aspergillosis And Systemic Candidiasis Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. Abbott Laboratories
31.3. Sanofi S.A.
31.4. GlaxoSmithKline PLC
31.5. Gilead Sciences Inc.
31.6. Regeneron Pharmaceuticals Inc.
31.7. Astellas Pharma Inc.
31.8. Matinas BioPharma Holdings Inc.
31.9. Shionogi & Co. Ltd
31.10. Cipla Limited
31.11. Taj Pharmaceuticals Limited
31.12. Basilea Pharmaceutica Ltd.
31.13. Cidara Therapeutics Inc.
31.14. T2 Biosystems Inc.
31.15. Sandoz International GmbH

32. Global Systemic Aspergillosis And Systemic Candidiasis Market Competitive Benchmarking

33. Global Systemic Aspergillosis And Systemic Candidiasis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Systemic Aspergillosis And Systemic Candidiasis Market

35. Systemic Aspergillosis And Systemic Candidiasis Market Future Outlook and Potential Analysis

35.1 Systemic Aspergillosis And Systemic Candidiasis Market In 2028 - Countries Offering Most New Opportunities
35.2 Systemic Aspergillosis And Systemic Candidiasis Market In 2028 - Segments Offering Most New Opportunities
35.3 Systemic Aspergillosis And Systemic Candidiasis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer